Baxter Net Worth 2012-2025 | BAX
Interactive chart of historical net worth (market cap) for Baxter (BAX) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Baxter net worth as of January 15, 2026 is $10.47B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $10.471B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $214.803B | 24.76 |
| EssilorLuxottica (ESLOY) | France | $151.023B | 0.00 |
| Stryker (SYK) | United States | $138.625B | 27.52 |
| Boston Scientific (BSX) | United States | $133.464B | 30.52 |
| Medtronic (MDT) | Ireland | $126.919B | 17.58 |
| Medline (MDLN) | United States | $56.109B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.167B | 0.00 |
| Agilent Technologies (A) | United States | $41.059B | 25.95 |
| ResMed (RMD) | United States | $38.047B | 26.33 |
| GE HealthCare Technologies (GEHC) | United States | $37.585B | 17.98 |
| Koninklijke Philips (PHG) | Netherlands | $29.051B | 18.98 |
| Terumo (TRUMY) | Japan | $20.817B | 23.43 |
| Insulet (PODD) | United States | $20.154B | 62.55 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.589B | 10.97 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.974B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.688B | 31.24 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.338B | 13.22 |
| BillionToOne (BLLN) | United States | $4.335B | 0.00 |
| Envista Holdings (NVST) | United States | $4.060B | 23.29 |
| ICU Medical (ICUI) | United States | $3.829B | 24.31 |
| Haemonetics (HAE) | United States | $3.464B | 15.42 |
| Prestige Consumer Healthcare (PBH) | United States | $3.155B | 14.39 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.403B | 15.45 |
| Perrigo (PRGO) | Ireland | $2.088B | 5.23 |
| AtriCure (ATRC) | United States | $2.061B | 0.00 |
| Neogen (NEOG) | United States | $2.058B | 45.05 |
| LeMaitre Vascular (LMAT) | United States | $1.962B | 39.50 |
| Curaleaf Holdings (CURLF) | Canada | $1.846B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.715B | 75.18 |
| Phibro Animal Health (PAHC) | United States | $1.624B | 16.22 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.459B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.441B | 20.86 |
| Kestra Medical Technologies (KMTS) | United States | $1.341B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.178B | 349.57 |
| Capricor Therapeutics (CAPR) | United States | $1.099B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.090B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.944B | 0.00 |
| InMode (INMD) | Israel | $0.888B | 10.04 |
| Omeros (OMER) | United States | $0.866B | 0.00 |
| Valneva SE (VALN) | France | $0.865B | 0.00 |
| CeriBell (CBLL) | United States | $0.847B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.581B | 15.75 |
| Cerus (CERS) | United States | $0.526B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.494B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| Brainsway (BWAY) | Israel | $0.452B | 77.00 |
| Canopy Growth (CGC) | Canada | $0.450B | 0.00 |
| SNDL (SNDL) | Canada | $0.426B | 0.00 |
| Quanterix (QTRX) | United States | $0.371B | 0.00 |
| Evolus (EOLS) | United States | $0.324B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.307B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.287B | 22.85 |
| TerrAscend (TSNDF) | Canada | $0.244B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| Sanuwave Health (SNWV) | United States | $0.238B | 0.00 |
| High Tide (HITI) | Canada | $0.220B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.215B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.212B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| Accendra Health (ACH) | United States | $0.196B | 1.96 |
| Utah Medical Products (UTMD) | United States | $0.193B | 17.02 |
| Vireo Growth (VREOF) | United States | $0.193B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.147B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.79 |
| Exagen (XGN) | United States | $0.109B | 0.00 |
| Biote (BTMD) | United States | $0.109B | 4.78 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Sharps Technology (STSS) | United States | $0.067B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.54 |
| Nephros (NEPH) | United States | $0.047B | 33.69 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.86 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Jin Medical (ZJYL) | China | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |